Endeavor

New Combination Therapy Brings Hope to Bladder Cancer Patients

Oncolytic immunotherapy and immune checkpoint inhibitor found to be safe and effective in treating muscle-invasive bladder cancer

New Immunotherapy Strategy Shows Promise in Lung Cancer Treatment

Moffitt researchers advance a novel approach to boost the immune system’s ability to target lung cancer cells

TIL Therapy for Advanced Melanoma Offers Promising Results

The study shows 36% of patients experienced a positive response to the therapy

New Immunotherapy Combination Shows Promise in Advanced Lung Cancer

Adding pembrolizumab to TIL therapy shrunk tumors in almost half of trial patients

Moffitt Experts Share Discoveries Driving Innovation in Cancer Immunotherapy

The Society for Immunotherapy of Cancer brings together industry leaders to highlight new research and clinical applications in immunotherapy

AI Helps Predict Treatment Response in Melanoma

Identifying and analyzing immune cells under the microscope can help personalize therapies

Oral Drug Shows Potential for Advanced Melanoma Treatment

HBI-8000 combined with nivolumab shows promise in a phase 2 trial at Moffitt

Moffitt Study Aims to Improve Personalized Cancer Vaccines

Selection of neoantigen target critical to therapy’s success

New Approach Using mRNA Generates Cellular Immunotherapy Within the Body

In vivo CAR macrophage therapy can be used to treat solid tumors